Improvement of postischemic hepatic microhemodynamics by an endothelin converting enzyme inhibitor (FR 901533).
Uhlmann
D
D
University of Leipzig, 2nd Department of Surgery, Leipzig, Germany.
Witzigmann
H
H
Senninger
N
N
Hauss
J
J
Spiegel
H
H
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D000818:Animals; D016282:Aspartic Acid Endopeptidases / Q000037:antagonists & inhibitors*; D000072396:Endothelin-Converting Enzymes; D005260:Female; D006439:Hemodynamics / Q000187:drug effects* / Q000502:physiology; D007511:Ischemia / Q000503:physiopathology*; D007962:Leukocytes / Q000187:drug effects / Q000502:physiology; D008099:Liver / Q000098:blood supply*; D008102:Liver Circulation / Q000187:drug effects* / Q000502:physiology; D008666:Metalloendopeptidases; D008833:Microcirculation / Q000187:drug effects* / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar; D013754:Tetracyclines / Q000494:pharmacology*
D000806:Angiotensin-Converting Enzyme Inhibitors; D013754:Tetracyclines; C088494:WS 79089B; D016282:Aspartic Acid Endopeptidases; D008666:Metalloendopeptidases; D000072396:Endothelin-Converting Enzymes